Oct 13, 2025 15:00
NAGE - Niagen Bioscience, Inc. Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 7.69 -0.19 (-2.47%) | --- | --- | -0.11 (-1.44%) | -0.16 (-2.08%) | -0.01 (-0.13%) | -0.12 (-1.57%) | -0.12 (-1.57%) |
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
Category:
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Market Period:
Closed
Earnings & Ratios
- Basic EPS:
- 0.05
- Diluted EPS:
- 0.04
- Basic P/E:
- 150.002
- Diluted P/E:
- 187.5025
- RSI(14) 1m:
- 0.0
- VWAP:
- 7.5
- RVol:
- 0.879
Events
| Period | Kind | Movement | Occurred At |
|---|